JoVE Logo

登录

4.4 : Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.

GPCRs are also called heptahelical, 7TM, or serpentine receptors and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three cytosolic loops. Together with the extracellular loops, the transmembrane alpha-helices include the central ligand-binding pocket of GPCR. In contrast, the heterotrimeric G protein binding site is the third cytosolic loop.

Ligand binding induces the GPCRs to undergo a conformational change and bind heterotrimeric G proteins with high affinity. An activated GPCR can bind and activate multiple G proteins to amplify the signal. G proteins, in turn, bind and activate downstream effectors and bring about a cellular response.

Although structurally, all mammalian GPCRs consist of seven transmembrane alpha-helical domains; they differ considerably in their sequence and functionality. GPCRs are broadly categorized into five classes, including Class A (rhodopsin-like), Class B (secretin receptor-like or B1), Class B2/ adhesion type, Class C (glutamate receptor-like), and Class F (frizzled-like).

  • Class A forms the largest subfamily of GPCRs that includes rhodopsins, chemokine receptors, and beta-adrenergic receptors.
  • Class B comprises hormone-binding receptors such as glucagon, parathyroid hormone, and vasoactive intestinal peptide (VIP) receptors.
    • The adhesion or B2 receptor class includes the adhesion G protein-coupled receptors or ADGR groups of receptors such as ADGRL1 and ADGRG1 that are essential for cell adhesion and migration.
  • Class C includes calcium-sensing receptors, gamma-aminobutyric acid (GABA) type B receptors, metabotropic glutamate receptors, and several taste receptors. Unlike the others, this group uses a characteristic venus fly trap module for ligand binding.
  • Class F, also called frizzled-like, includes smoothened or Smo receptors and functions in embryonic development.

Overall, humans consist of more than 800 GPCRs. Many detect hormones, growth factors, or endogenous ligands, while several others are involved in olfactory and gustatory responses. One commonly used class of drugs, beta-blockers, target beta-adrenergic receptors and treat conditions such as hypertension, cardiac arrhythmia, and anxiety. GPCRs provide an effective target to create an arsenal for various diseased conditions.

Tags

G Protein Coupled ReceptorsGPCRsHeterotrimeric G ProteinsDrug TargetsMembrane bound ReceptorsTransmembrane Alpha helicesLigand BindingConformational ChangeCellular ResponseClass A ReceptorsClass B ReceptorsClass C ReceptorsCell AdhesionSignal AmplificationTherapeutic Effects

来自章节 4:

article

Now Playing

4.4 : Transducer Mechanism: G Protein–Coupled Receptors

Pharmacodynamics

1.8K Views

article

4.1 : 药物作用原则

Pharmacodynamics

5.7K Views

article

4.2 : 药物作用的目标:概述

Pharmacodynamics

5.9K Views

article

4.3 : 信号转导:概述

Pharmacodynamics

8.1K Views

article

4.5 : 配体门控离子通道受体:门控机制

Pharmacodynamics

2.1K Views

article

4.6 : 换能器机制:酶联受体

Pharmacodynamics

2.3K Views

article

4.7 : 换能器机制:核受体

Pharmacodynamics

1.2K Views

article

4.8 : 剂量-反应关系:概述

Pharmacodynamics

2.9K Views

article

4.9 : 剂量-反应关系:效力和疗效

Pharmacodynamics

4.1K Views

article

4.10 : 剂量-反应关系:选择性和特异性

Pharmacodynamics

6.3K Views

article

4.11 : 治疗指数

Pharmacodynamics

4.0K Views

article

4.12 : 药物-受体相互作用:激动剂

Pharmacodynamics

2.3K Views

article

4.13 : 药物-受体相互作用:拮抗剂

Pharmacodynamics

2.6K Views

article

4.14 : 药物的综合作用:拮抗作用

Pharmacodynamics

8.2K Views

article

4.15 : 药物的综合作用:协同作用

Pharmacodynamics

3.7K Views

See More

JoVE Logo

政策

使用条款

隐私

科研

教育

关于 JoVE

版权所属 © 2025 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。